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Background: Nestin was reported to directly contribute to cell proliferation and the intermediate filament protein
was detected in vascular smooth muscle cells. In experimental type I diabetes, nestin downregulation in the heart
was identified as an incipient pathophysiological event. The following study tested the hypothesis that
dysregulation of nestin expression in vascular smooth muscle cells represented an early event of vascular disease
in experimental type I diabetes.
Methods/Results: In the carotid artery and aorta of adult male Sprague-Dawley rats, a subpopulation of vascular
smooth muscle cells co-expressed nestin and was actively involved in the cell cycle as reflected by the co-staining
of nuclear phosphohistone-3. The infection of aortic vascular smooth muscle cells with a lentivirus containing a
shRNAmir directed against nestin significantly reduced protein expression and concomitantly attenuated basal DNA
synthesis. Two weeks following injection of adult male Sprague-Dawley rats with streptozotocin, the endothelial
response of aortic rings to acetylcholine, vascular morphology and the total density of vascular smooth muscle
cells in the vasculature of type I diabetic rats were similar to normal rats. By contrast, nestin protein levels and the
density of nestin(+)/phosphohistone-3(+)-vascular smooth muscle cells were significantly reduced in type I diabetic
rats. The in vivo observations were recapitulated in vitro as exposure of vascular smooth muscle cells to 30 mM
D-glucose inhibited DNA synthesis and concomitantly reduced nestin protein expression.
Conclusions: Hyperglycaemia-mediated nestin downregulation and the concomitant reduction of cycling vascular
smooth muscle cells represent early markers of vascular disease in experimental type I diabetes.
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Type I diabetes accounts for 5-10% of the diabetic popula-
tion and is characterized by the depletion of insulin syn-
thesis secondary to pancreatic beta cell destruction [1].
Thus, hyper-glycaemia represents a chronic condition of
type I diabetes and elevated plasma glucose levels was re-
ported as the third major cause of global mortality [1].
Type II diabetes account for 90-95% of the diabetic popu-
lation and is characterized by the reduced sensitivity of
peripheral tissue to circulating insulin [1]. In this regard, a* Correspondence: angelo.calderone@umontreal.ca
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unless otherwise stated.hypersecretion of insulin is chronically observed and
ultimately leads to pancreatic beta cell exhaustion [1]. A
major complication of diabetes is micro- and/or macro-
vascular disease in nearly all organs [1,2]. Microvascular
complications include retinopathy, nephropathy, and neu-
ropathy whereas macrovascular complications constitute
the rapid acceleration of cardiovascular and cerebrovascu-
lar disease secondary to stroke [1,2]. An incipient patho-
physiological event of diabetic vascular disease was an
imbalance of homeostasis due to increased vasoconstric-
tion secondary to impaired endothelial cell reactivity that
occurred prior to the onset of overt clinical symptoms
[1-3]. The underlying mechanisms included reduced bio-
availability of nitric oxide secondary to the increasedtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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peroxynitrite and/or compromised activity of endothelial
nitric oxide synthase [1-3]. Vascular smooth muscle cell
dysfunction likewise contributed to the progression of ves-
sel disease in experimental models of diabetes and diabetic
patients, albeit it remains presently unknown whether it
occurred prior to, concomitantly or after impaired endo-
thelial reactivity was established [1,2,4].
Nestin, a class VI intermediate filament protein was first
detected in a population of neural progenitor/stem cells
residing in the CNS [5]. However, several studies have
identified nestin in developing skeletal myoblasts, endo-
thelial cells during reparative angiogenesis and tumour
vascularisation, upregulated in the infarcted heart, de-
tected in diverse forms of cancer and a biological role in
proliferation and/or migration was reported [6-13]. A re-
cent study by Oikawa and colleagues demonstrated that
nestin was expressed in vascular smooth muscle cells of
the adult rat aorta [14]. Work from our lab detected a
population of cardiac resident nestin-expressing cells that
exhibited a neural progenitor/stem cell phenotype and
downregulation of the intermediate filament protein was
identified as an incipient pathophysiological event of type
I diabetes [8,9,15,16]. Based on these observations, the
present study tested the hypothesis that nestin expression
in vascular smooth muscle cells (VSMCs) of the adult rat
carotid artery and aorta was directly linked to proliferation
and the intermediate filament protein was downregulated




Vascular phenotype was determined in the aorta of neo-
natal Sprague-Dawleys rats (2-3 day old; Charles Rivers,
Canada), carotid artery and aorta of adult male Sprague–
Dawley rats (9–11 weeks old; Charles Rivers, Canada). Ex-
perimental type I diabetes was induced following a single
injection of streptozotocin (60 mg/kg) in the jugular vein
of adult male Sprague-Dawley rats (9–11 weeks old)
[15,16]. Plasma glucose levels and left ventricular function
were determined as previously described [16]. The use
and care of laboratory rats was according to the Canadian
Council for Animal Care and approved by the Animal
Care Committee of the Montreal Heart Institute.
Endothelial reactivity of aortic rings
The endothelial function of aortic rings was determined
in organ chambers as previously described [17].
Vessel morphology
Formalin fixed 6-8 μm thick sections of the carotid ar-
tery and aorta were stained with haematoxylin-phloxin-
saffron (HPS) and images captured with the OlympusQICAM colour video camera interfaced with an Olympus
CKX41 microscope. Vessel wall media thickness (mm)
and media area (mm2) were measured with Image-Pro
(version 7, Media Cybernetics, Rockville, MD).
Vascular smooth muscle cells (VSMCs)
The carotid artery and aorta of adult male Sprague-
Dawley rats (9–11 weeks old) were cut longitudinally
and the lumen gently rubbed with a cotton swab to re-
move the endothelium. Vessel segments of 3-5 mm in
length were digested in Dulbecco’s modified Eagle’s
medium (DMEM; low glucose; HyClone Laboratories,
Logan, UT) containing collagenase (type II; 1 mg/ml) for
5 hours at 37°C. Cells were filtered (40 μm nylon mesh;
Corning, NY), cultured in DMEM supplemented with
10% FBS (Invitrogen Life Technologies, Grand Island,
NY), 2% penicillin-streptomycin, 1% fungizone, epider-
mal growth factor (25 ng/ml), basic fibroblast growth
factor (10 ng/ml) and grown until confluent. Experi-
ments were subsequently performed on 1st/2nd passage
VSMCs plated at a density of 125-150 cells/mm2 in
DMEM-containing 10% FBS for 24 hours. Thereafter,
VSMCs were washed and the media replaced with
DMEM supplemented with insulin/transferring/selenium
(BD Bioscience, Bedford, MA) for 48 hours. To assess
the effect of hyperglycaemia, VSMCs were plated in
DMEM containing 5 mM D-glucose for 48 hours and
thereafter supplemented with 25 mM D-glucose (Sigma,
St-Louis MO), 30 mM L-glucose (Sigma) or 30 mM
mannitol (Sigma) for 24 or 48 hours. DNA and protein
synthesis was determined by 3H-thymidine and 3H-leucine
uptake respectively, as previously described [10].
Immunofluorescence
Formalin fixed 6-8 μm thick sections were subjected to
the antigen retrieval method and stained with the
mouse monoclonal anti-nestin (1:150; Chemicon, Temi-
cula, CA), rabbit polyclonal anti-smooth muscle α-actin
(1:100; Abcam, Cambridge, MA), goat monoclonal anti-
CD31 (1:100; SantaCruz Biotechnologies, Santa Cruz, CA)
or a rabbit polyclonal anti-phosphohistone-3 directed
against phosphorylated serine 10 (1:100; Abcam). Primary
and 1st/2nd passage VSMCs were plated on glass coverslips
for ~48 hours, fixed with 4% paraformaldehyde and
stained with the mouse monoclonal anti-nestin (1:500;
Chemicon), rabbit polyclonal anti-smooth muscle α-actin
(1:200; Abcam), rabbit polyclonal anti-caldesmon (1:500;
Abcam) or a rabbit polyclonal anti-smooth muscle-22α
(1:1000; Abcam). The nucleus was identified with To-
PRO-3 (InVitrogen; 1.5 μM) or 4′,6′-diamidino-2-pheny-
lindole (DAPI, Sigma; 1.5 μM) and used to calculate total
cell density normalized to the field (mm2). Secondary anti-
bodies used were a goat anti-mouse IgG conjugated-
Alexa-555 (1:800; InVitrogen) or a goat anti-rabbit IgG
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cence was visualized using a confocal LSM710 Zeiss micro-
scope with the Zeiss LSM Image Browser. The density of
nestin(+)- and phosphohistone-3(+)-VSMCs were deter-
mined with maximum projections derived from a z-stack
(voxel size of 143x143x250 nm in XYZ) and normalized to
the vessel area (mm2; average of at least 3-4 distinct fields).
Non-specific staining was determined following the
addition of the conjugated secondary antibody alone.
Western blot
Lysates (30-50 μg) were prepared from the carotid artery,
aorta or VSMCs, subjected to SDS-polyacrylamide gel
(10%) electrophoresis and transferred to a PVDF mem-
brane (Perkin Elmer Life Sciences, Boston, MA) [16]. Anti-
bodies used include a mouse monoclonal anti-nestin (1:500;
Chemicon), mouse monoclonal anti-eNOS (1:500; BD Bio-
science), goat monoclonal anti-CD31 (1:500; SantaCruzFigure 1 Nestin expression in neonatal and adult rat vessels. Nestin, C
neonatal aortic arch, (Panel C) adult aortic arch, (Panel D) adult thoracic reg
luminal side and the nucleus identified by DAPI (blue fluorescence). (Panel
compared to the thoracic (TA) and abdominal (AB) regions of the adult rat
were unchanged. (*) Denotes P < 0.05 versus AA and protein levels were nBiotechnologies), rabbit polyclonal anti-caldesmon (1:2500;
Abcam), rabbit polyclonal anti-smooth muscle-22α (1:5000;
Abcam), rabbit polyclonal anti-smooth muscle α-actin
(1:5000; Abcam), and mouse monoclonal anti-GAPDH
(1:50,000; Ambion, Austin TX). Following overnight
incubation at 4°C, the appropriate secondary antibody-
conjugated to horseradish peroxidase (1:20,000, Jackson
Immunoresearch, West Grove, PA) was added and bands
visualized utilizing the ECL detection kit (Perkin Elmer).
Films were scanned with Image J software® and the target
protein signal was depicted as arbitrary light units normal-
ized to GAPDH protein levels.
Lentiviral construct
The lentiviral construct containing the shRNAmir directed
against nestin was prepared as previously described [10].
The biological impact of the empty lentivirus and the
lentivirus containing the shRNAmir directed againstD31 and smooth muscle α-actin (SMA) staining of (Panels A & B) the
ion and (Panels E & F) adult rat carotid artery. The arrow indicates the
G) Nestin expression was greatest in the aortic arch (AA) as
aorta, whereas CD31, eNOS and smooth muscle α-actin protein levels
ormalized to GAPDH.
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3H-thymidine uptake of infected aortic-derived VSMCs, as
previously described [10].
Statistics
Data are presented as the mean ± S.E.M and (n) represents
the number of rats or individual preparation of VSMCs
used per experiment. Data was evaluated by a one-way
ANOVA (GraphPad InStat) and a significant difference
determined by the Student Newman-Keuls Multiple Com-
parisons post-hoc test or by a student’s unpaired t-test and
a value of P < 0.05 considered statistically significant.
Results
Temporal and spatial pattern of nestin expression in the
vasculature during physiological development
In the aortic arch of 1-3 day old neonatal Sprague-Dawley
rats, nestin immunoreactivity was detected in CD31(+) endo-
thelial cells (Figure 1A). Nestin staining of a subpopulationFigure 2 Phenotype of cultured VSMCs. (Panel A) Lineage
specific markers were expressed in carotid artery and aortic VSMCs.
(Panel B) Filamentous nestin was detected in caldesmon and
smooth muscle-22α(+)-VSMCs. The nucleus was identified by
To-PRO-3 (blue fluorescence).of smooth muscle α-actin(+)-VSMCs was variable among
neonatal rats as expression was modest or completely ab-
sent in the media of the aortic arch (Figure 1B). In the
aortic arch of adult male Sprague-Dawley rats, nestin im-
munoreactivity persisted in CD31(+) endothelial cells and a
subpopulation of VSMCs in the medial region expressed
the intermediate filament protein (Figure 1C). Nestin im-
munoreactivity was identified in 20 ± 2% (N= 6, Figure 1C)
of smooth muscle α-actin(+)-VSMCs residing predominantly
in close proximity to the lumen of the adult aortic arch and
occupied a density of 641 ± 89 cells/mm2 (N = 6). In the






























Figure 3 Nestin depletion and DNA synthesis. (Panel A) Aortic
VSMCs infected with a lentivirus containing a shRNAmir directed
against nestin reduced protein expression, whereas smooth muscle
α-actin (SMA), caldesmon and smooth muscle-22α protein levels
were unchanged. (Panel B) In nestin-depleted aortic VSMCs,
3H-thymidine uptake was significantly decreased. (*) Denotes
P < 0.05 versus VSMCs infected with the empty lentivirus.
Figure 4 Nestin(+)-VSMCs were actively involved in the cell cycle;
impact of type I diabetes. A subpopulation of nestin(+)-VSMCs and
nestin(+)-endothelial cells in the (Panel A) carotid artery and (Panel C)
aorta arch of normal adult rats were associated with nuclear PHH3
staining. In type I diabetic rats, the subpopulation of nestin(+)-VSMCs
co-expressing nuclear PHH3 staining in the (Panel B) carotid artery and
(Panel D) aortic arch was reduced and nestin/PHH3 co-staining of
endothelial cells was also diminished. The arrow indicates the luminal
side and the nucleus was identified by DAPI (blue fluorescence).
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tected in the media but the percentage (11 ± 4%, Figure 1D)
and density (276 ± 90 cells/mm2; N = 6) were significantly
lower (P < 0.01) as compared to the aortic arch. The per-
centage (6 ± 2%) and density (170 ± 46 cells /mm2; N = 6)
of nestin(+)/smooth muscle α-actin(+)-VSMCs in theTable 1 Vascular remodeling of the carotid artery and aorta o
Aortic arch
Sham (N = 6) S
Total density (cells/mm2) 3114 ± 204 2
PHH3(+) (cells/mm2) 1032 ± 201 1
PHH3(+)/Nestin(-) (cells/mm2) 645 ± 131 8
Nestin(+) (cells/mm2) 641 ± 89 3
PHH3(+)/Nestin(+) (cells/mm2) 387 ± 77 5
STZ indicates streptozotocin-induced diabetic rats, data are presented as mean ± SEM,
of rats examined.abdominal aorta likewise remained significantly lower
(P < 0.01) as compared to the aortic arch. The spatial
disparity in the density of nestin(+)-VSMCs in the adult
rat aorta was reaffirmed as expression of the inter-
mediate filament protein was highest in the aortic arch
and significantly lower in the thoracic and abdominal
regions whereas smooth muscle α-actin protein levels
were unchanged (Figure 1G). Nestin immunoreactivity of
CD31(+)-endothelial cells persisted in the thoracic and
abdominal regions and CD31 and eNOS protein expres-
sion was similar throughout the adult aorta (N = 3-4)
(Figure 1G). In the carotid artery of adult male Sprague-
Dawley rats, a subpopulation of smooth muscle α-actin(+)-
VSMCs co-expressed nestin (26 ± 1%; 590 ± 72 cells/mm2;
N = 4) and the intermediate filament protein was also de-
tected in CD31(+)-endothelial cells (Figure 1E & F).
To reaffirm nestin expression in a vascular smooth
muscle cell lineage, carotid artery and aortic VSMCs
were isolated, cultured and stained with smooth muscle
α-actin, caldesmon and smooth muscle-22α. The vascu-
lar smooth muscle cell phenotype of primary and 1st/
2nd passage cells (N = 4-5) was confirmed and nestin-
immunoreactive filaments were detected in caldesmon(+)/
smooth muscle-22α(+)/smooth muscle α-actin(+)-VSMCs
(Figure 2A & B).
Biological role of nestin
First passage aortic-derived VSMCs infected with a
lentivirus containing a shRNAmir directed against nestin
(N = 4) led to a significant reduction in the expression
of the intermediate filament protein, whereas lineage
specific markers were unaffected (Figure 3A). These
data were reaffirmed by immunofluorescence as stain-
ing was diminished in aortic VSMCs infected with the
lentivirus containing the shRNAmir directed against
nestin (Additional file 1: Figure S1). DNA synthesis, as
measured by 3H-thymdine uptake was significantly at-
tenuated in nestin-depleted 1st passage aortic VSMCs
(N = 4) (Figure 3B).
The established proliferative role of nestin suggested
that a subpopulation of VSMCs expressing the intermedi-
ate filament protein in the vasculature of normal adult ratsf normal and streptozotocin-induced type I diabetic rats
Carotid artery
TZ (N = 6) Sham (N = 4-5) STZ (N = 4-5)
693 ± 284 2869 ± 223 2710 ± 237
37 ± 28* 797 ± 124 416 ± 108*
4 ± 18* 430 ± 73 273 ± 87*
85 ± 48* 590 ± 72 355 ± 64*
2 ± 15* 368 ± 62 143 ± 36*
analyzed by unpaired t-test, (*) represents P < 0.05 versus sham and (N) number
Table 2 Cardiac function of normal and streptozotocin-induced type I diabetic rats
BW MAP LVSP LVEDP LV + dP/dT LV -dP/dT Plasma
glucose(g) (mmHg) (mmHg) (mmHg) (mmHg/sec) (mmHg/sec)
Sham (N = 5) 312 ± 1 117 ± 3 148 ± 8 8 ± 1 6963 ± 188 6069 ± 172 10 ± 2
STZ (N = 5) 263 ± 2* 87 ± 1* 109 ± 1* 10 ± 1 5656 ± 79* 4155 ± 53* 29 ± 1*
STZ indicates streptozotocin-induced diabetic rats, BW, body weight, MAP, mean arterial pressure, LVSP, left ventricular systolic pressure, LVEDP, left ventricular
end-diastolic pressure, +dp/dt, rate of contraction; -dp/dt rate of relaxation, LV, data are presented as mean ± SEM, analyzed by unpaired t-test, (*) represents
P < 0.05 versus sham and (N) number of rats examined.
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cycle entry in vivo, phosphohistone-3 (PHH3) immunore-
activity characterized by the phosphorylation of serine 10
was examined [18]. Consistent with its proliferative role, a
significant population of nestin(+)-VSMCs in the carotid
artery and aortic arch of normal adult rats was asso-
ciated with nuclear PHH3 staining (Figure 4A,C &
Table 1). Furthermore, nestin(+)-endothelial cells in the
vasculature of normal adult rats co-expressed nuclear
PHH3 (Figure 4A & C).
Streptozotocin-induced type I diabetes in the adult rat;
endothelial reactivity and morphological/cellular vascular
remodeling
Plasma glucose levels were increased and left ventricular
contractility was significantly depressed 2 weeks after
streptozotocin (STZ) injection of adult male rats (Table 2).
Following pre-contraction with phenylephrine, acetylcho-
line treatment led to a dose-dependent relaxation of nor-
mal aortic rings and a quantitatively analogous response
was observed in STZ-induced diabetic rats (Figure 5A).
Consistent with the latter data, CD31 and eNOS protein
levels (normalized to GAPDH) in the aorta and carotid
artery of STZ-induced type I diabetic rats (N = 4-6)
were comparable to normal rats (N = 4) (Figure 5B & C).
Vascular morphology as measured by the media area and
media thickness of the carotid artery and aorta were also
similar in normal and type I diabetic rats (Table 3 &
Additional file 2: Figure S2).
The total density of VSMCs (as measured by nuclear
staining) in the carotid artery and aortic arch of STZ-
induced type I diabetic rats and normal rats were not
significantly different (Table 1). However, a significant
loss in the density of VSMCs expressing nestin (Table 1)
was observed in the carotid artery (Figure 4B) and aortic
arch (Figure 4D) of type I diabetic rats. The data were
reaffirmed as nestin protein expression was significantly
reduced in the vasculature of type I diabetic rats as com-
pared to normal rats (Figure 5B & C). The established
proliferative role suggested that the reduced density of
nestin(+)-VSMCs in the carotid artery and aortic arch of
STZ-induced diabetic rats may be associated in part with
a concomitant loss in the number of cycling cells. In the
vasculature of STZ-induced diabetic rats, the density
of PHH3(+)-VSMCs and nestin(+)-VSMCs co-expressingnuclear PHH3 were significantly decreased (Figure 4B & D;
Table 1). Lastly, nestin and PHH3 staining was apparently
reduced in endothelial cells lining the vasculature of type I
diabetic rats (Figure 4B & D).
Hyperglycaemia inhibited DNA synthesis and reduced
nestin protein expression in VSMCs
A 24 hour exposure of 1st/2nd passage carotid artery and
aortic VSMCs to 30 mM mannitol or L-glucose had no
effect on nestin protein expression or lineage specific
markers, as compared to cells treated with DMEM (N =
4-6) (Figure 6A & Additional file 3: Figure S3). The ex-
posure of carotid artery VSMCs to 30 mM D-glucose for
24 and 48 hrs significantly downregulated nestin protein
expression, whereas smooth muscle α-actin, caldesmon
and smooth muscle-22α protein levels were unchanged
(N = 4-6) (Figure 6A,B and Additional file 4: Figure S4).
The exposure of aortic VSMCs to 30 mM D-glucose for
24 hrs did not have a significant effect on nestin protein
expression whereas a downregulation of the intermediate
filament protein was observed after a 48 hr exposure (N =
4-6) (Additional file 3: Figure S3). The 24 or 48 hr expos-
ure of aortic VSMCs to 30 mM D-glucose did not influ-
ence the expression of lineage specific markers (Additional
file 3: Figures S3 & Additional file 4: Figure S4). DNA syn-
thesis, as measured by 3H-thymidine uptake was signifi-
cantly decreased following a 24 hr exposure of VSMCs to
30 mM D-glucose (N = 4-6) (Figure 6C). By contrast, the
density of VSMCs, as measured by nuclear staining (aortic
VSMCs; L-glucose 51 ± 2 versus D-glucose 59 ± 7 cells/mm2;
N = 3) and 3H-leucine uptake, a global index of protein
synthesis were unchanged following exposure to 30 mM
D-glucose (N = 4-6) (Figure 6D).
Discussion
Nestin was first identified as a selective marker of CNS-
derived neural progenitor/stem cells [5]. However, nestin
expression was also reported in developing skeletal myo-
blasts, detected in endothelial cells during reparative angio-
genesis and tumour vascularisation, upregulated in the
infarcted heart and identified in diverse forms of cancer
[6-11,19,20]. Oikawa and colleagues recently demonstrated
that VSMCs of the adult rat aorta expressed nestin [14].
The present study has reaffirmed the latter findings and
further revealed that nestin was also expressed in a
Figure 5 Endothelial reactivity and nestin expression in type I
diabetic rats. (Panel A) Acetylcholine-mediated relaxation of
pre-contracted aortic rings was comparable in sham (N = 3) and
streptozotocin (STZ, N = 3) induced type I diabetic rats. Nestin
expression in the (Panel B) carotid artery and (Panel C) aorta of type
I diabetic rats was significantly reduced, whereas CD31 and eNOS
levels were unchanged. (*) Denotes P < 0.05 versus sham and
protein levels normalized to GAPDH.
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male rats. As reported by Oikawa and colleagues [14], a
spatial disparity in the density of nestin(+)-VSMCs was
identified as a greater population was observed in the aor-
tic arch versus the thoracic and abdominal aortic regions
of adult male rats. Consistent with the latter data, nestin
protein expression was highest in the aortic arch and sig-
nificantly lower in the thoracic and abdominal regions,
whereas smooth muscle α-actin protein levels were
comparable in the three regions of the aorta. Lastly, the
in vivo immunofluorescence data was confirmed in vitro
as nestin(+)-filaments were detected in primary and 1st/
2nd passage carotid artery and aortic VSMCs character-
ized by smooth muscle α-actin, caldesmon and smooth
muscle-22α co-staining.
To ascertain the biological role, nestin expression was
depleted with a lentivirus containing a shRNAmir that
selectively targeted the intermediate filament protein
[10]. Lentiviral shRNAmir-mediated depletion of nestin in
aortic-derived VSMCs significantly attenuated basal 3H-
thymidine uptake demonstrating that the intermediate
filament protein participated in cell cycle entry. Based on
these observations, an analogous paradigm may be preva-
lent in nestin-expressing VSMCs in the vasculature of
adult rats. To examine the latter issue in vivo, immunore-
activity of phosphohistone H3 (PHH3); an established cell
cycle protein that was directly phosphorylated on the resi-
due serine 10 during chromosome condensation in G2/M
phase was examined [18]. In the carotid artery and aortic
arch of adult rats, a significant population of nestin(+)-
VSMCs were actively engaged in the cell cycle as nuclear
PHH3 co-staining was identified. Nestin staining of
CD31(+)-endothelial cells in the vasculature of adult rats
was also associated with nuclear PHH3 immunoreactivity.
The latter findings were in stark contrast to that of
Oikawa and colleagues [14] as their study did not detect
nestin immunoreactivity in endothelial cells in the aorta of
adult rats. Previous studies have reported nestin expres-
sion in proliferating endothelial cells in the developing
pancreas, during wound healing and tumor vascularisation
[8,11,19,20]. However, nestin(+)-endothelial cells in the ca-
rotid artery and aorta of normal adult male rats were also
actively engaged in proliferation as revealed by nuclear
PHH3 co-staining. Therefore, these data suggest that
nestin expression in proliferating endothelial cells was
not restricted to de novo blood vessel formation during
physiological development and pathological remodeling.
Work from our lab has reported that nestin downreg-
ulation in the heart of type I diabetic rats was identified
as an incipient pathophysiological event and contributed
in part to the impaired neurogenic response of neural
progenitor/stem cells during the reparative fibrotic re-
sponse of the type I diabetic infarcted rat heart [15,16].
These observations provided the impetus to test the
Table 3 Vascular morphology of the carotid artery and aorta of normal and streptozotocin-induced type I diabetic rats
Carotid artery Aortic arch Thoracic aorta Abdominal aorta
Sham (N = 4) STZ (N = 4) Sham (N = 4) STZ (N = 4) Sham (N = 4) STZ (N = 4) Sham (N = 4) STZ (N = 4)
Medial thickness (mm) 0.063 ± 0.002 0.066 ± 0.002 0.15 ± 0.01 0.12 ± 0.01 0.11 ± 0.01 0.10 ± 0.01 0.10 ± 0.01 0.09 ± 0.01
Medial area (mm2) 0.147 ± 0.006 0.148 ± 0.011 0.82 ± 0.06 0.82 ± 0.04 0.59 ± 0.08 0.55 ± 0.05 0.44 ± 0.01 0.55 ± 0.01
STZ indicates streptozotocin-induced diabetic rats, data are presented as mean ± SEM, and (N) number of rats examined.
Figure 6 Hyperglycaemia, nestin expression and DNA synthesis in VSMCs. (Panels A & B) Exposure of 1st/2nd passage carotid artery VSMCs
to 30 mM mannitol or 30 mM L-glucose for 24 hours did not influence nestin protein expression as compared to DMEM. A 24 and/or 48-hour
exposure to 30 mM D-glucose significantly reduced nestin protein levels, whereas smooth muscle α-actin (SMA), caldesmon and smooth muscle-
22α protein expression was unchanged. (*) Denotes P < 0.05 versus L-glucose and protein levels normalized to GAPDH. (Panel C) VSMCs exposed
to 30 mM D-glucose for 24 hours attenuated 3H-Thymidine uptake. VSMCs treated with 10% FBS increased 3H-thymidine uptake, whereas 30 mM
mannitol and 30 mM L-glucose had no effect (Panel D) VSMCs exposed to 30 mM D-glucose, 30 mM L-glucose or 30 mM mannitol for 24 hours
had no effect on 3H-Leucine uptake, whereas a robust increase was observed with 10% FBS. Results are presented as % change versus DMEM
and (*) denotes P < 0.05 versus L-glucose/mannitol.
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VSMCs may represent an early event of vascular disease
in type I diabetes. Two weeks following streptozotocin
(STZ) injection of adult male rats, plasma glucose levels
were elevated and associated with left ventricular
contractile dysfunction. Previous studies have reported
that hyperglycemia-induced increase in oxidative stress
was directly implicated in endothelial dysfunction and
identified as an early pathological event of diabetes prior
to the overt manifestation of symptoms [1-3]. In the pre-
sent study, the vasorelaxant response of aortic rings to
acetylcholine and eNOS and CD31 protein levels in the
aorta during the early phase of experimental type I dia-
betes were similar to normal rats. In addition, the total
density of VSMCs and morphological remodeling of the
carotid artery and aorta were also comparable in normal
and type I diabetic rats. However, nestin protein levels and
the density of VSMCs expressing nestin and nuclear
PHH3 were significantly reduced in the carotid artery and
aortic arch of type I diabetic rats. These findings support
the premise that despite the absence of a change in the
total density of VSMCs in the vasculature of type I dia-
betic rats, a significant population was unable to re-enter
the cell cycle as reflected by the concomitant downregula-
tion of nestin and PHH3 expression. The immunofluores-
cence data further revealed that nestin and PHH3 staining
was decreased in endothelial cells in the vasculature of
type I diabetic rats, thereby suggesting that the prolifera-
tive response was also compromised.
In vitro experiments were performed to assess whether
the reduced density of cycling VSMCs in STZ-induced
diabetic rats was directly attributed to elevated plasma glu-
cose levels. Previous studies have reported that cultured
VSMCs exposed to high glucose significantly increased,
decreased or had no effect on proliferation [21-24]. The
underlying reasons for the disparate in vitro findings re-
main unknown. Therefore, to limit the potential spurious
effects of long-term culturing, the impact of elevated glu-
cose was examined exclusively on 1st/2nd passage VSMCs.
The 24 hour exposure of 1st/2nd passage carotid artery and
aortic VSMCs to 30 mM D-glucose significantly attenu-
ated DNA synthesis, as reflected by the decreased uptake
of 3H-thymidine. By contrast, the density of VSMCs and
3H-leucine uptake were unchanged following a 24 hour
exposure to 30 mM D-glucose. The in vitro data recapitu-
lated the in vivo findings as the total density of vascular
smooth muscle cells was unchanged in the vasculature
during the early phase of STZ-induced diabetes albeit a
significant population was unable to re-enter the cell cycle.
Moreover, the downregulation of nestin protein levels in
VSMCs of STZ-induced diabetic rats was attributed in
part to hyperglycemia as exposure of 1st/2nd passage ca-
rotid artery and aortic VSMCs to 30 mM D-glucose sig-
nificantly reduced expression, whereas lineage specificmarkers were unaffected. A similar paradigm was reported
following renal damage secondary to experimental type I
diabetes as nestin expression was reduced in podocytes
mediated by elevated plasma glucose levels [25,26]. Thus,
the hyperglycemic environment of experimental type I dia-
betes contributed in part to the loss of nestin expression in
the vasculature and downregulation of the intermediate
filament protein may further represent an incipient event
attenuating the re-entry of VSMCs in the cell cycle.
A seminal finding of the present study was the apparent
physiological turnover of a subpopulation of nestin(+)-
VSMCs in the carotid artery and aorta of normal adult
male rats characterized by concomitant nuclear PHH3
staining. During the early phase of experimental type I
diabetes, endothelial reactivity, vessel morphology and
the total density of VSMCs were similar to normal rats.
However, the density of VSMCs co-expressing nestin and
PHH3 in the vasculature of STZ-induced diabetic rats was
significantly reduced. The latter paradigm was recapitu-
lated in vitro as the acute exposure of VSMCs to 30 mM
D-glucose significantly reduced nestin protein levels and
attenuated DNA synthesis. Collectively, these data support
the novel premise that hyperglycaemia-mediated nestin
downregulation and the concomitant reduction of cycling
VSMCs represent early markers of vascular disease in ex-
perimental type I diabetes that occurred prior to the onset
of impaired endothelial reactivity.Additional files
Additional file 1: Figure S1. Lentivirus-sHRNAmir directed against
nestin. (Panel A) The infection of aortic vascular smooth muscle cells with
the empty lentivirus expressing the reporter green fluorescent protein
(GFP) had no significant effect on nestin immunoreactivity. (Panel B)
The infection of aortic vascular smooth muscle cells with a lentivirus
containing a shRNAmir directed against nestin significantly reduced
staining of the intermediate filament protein.
Additional file 2: Figure S2. Vascular morphology. The media thickness
and area of the carotid artery (CA) and aortic arch (AA) of streptozotocin
(STZ) induced type I diabetic rats were similar to sham rats.
Additional file 3: Figure S3. Hyperglycaemia downregulated nestin
protein expression in aortic VSMCs. The exposure of (Panels A & B) aortic
VSMCs to 30 mM mannitol or 30 mM L-glucose for 24 hrs did not
significantly influence nestin protein expression as compared to DMEM.
A 48 hr exposure of aortic-derived VSMCs to 30 mM D-glucose significantly
reduced nestin protein levels, as compared to 30 mM L-glucose treated cells,
whereas smooth muscle α-actin (SMA), caldesmon and smooth muscle-22α
protein expression was unchanged. (*) Denotes p< 0.05 versus L-glucose
and data normalized to GAPDH.
Additional file 4: Figure S4. The impact of hyperglycaemia on vascular
smooth muscle cells. A 24 and/or 48 hour exposure of (Panel A) carotid
artery (n=4-6) and (Panel B) aortic derived (n=4-6) vascular smooth
muscle cells to 30 mM D-glucose had no significant effect on smooth
muscle α-actin, caldesmon and smooth muscle-22α protein expression as
compared to 30 mM L-glucose. Proteins levels were normalized to GAPDH.Competing interests
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